pAYE4603 bp600120018002400300036004200AmpR promoterAmpRoriCAP binding sitelac promoterlac operatorM13 revVWF A1-pIII fusion proteinM13 fwdf1 ori

基本信息

载体名称
pAYE
载体抗性
Ampicillin
载体长度
4603 bp
载体类型
Phagemid vector
复制子
ori
载体来源
Yee A, Tan F-L., Ginsburg D.

质粒操作方法

质粒复溶方法

  1. 发货形式:质粒干粉,常温运输,收到后请于 -20 ℃ 保存,先转化提质粒再使用。
  2. 收到干粉后先 5000 rpm 离心 1 min,加入 20 μl ddH₂O 溶解。质粒复测浓度与标称值可能有差距,这通常来自干粉在管中的位置、复溶效率、测量偏差与管壁吸附,建议先转化提质粒后再使用。
  3. 取 1 支 100 μl 感受态细胞冰上解冻 10 min,加入 2 μl 质粒,冰浴 30 min,42 ℃ 热激 60 s(不要摇动),再冰浴 2 min。
  4. 加入 900 μl 无抗生素 LB 液体培养基,180 rpm、37 ℃ 振荡培养 45 min(30 ℃ 培养 1–1.5 h)。
  5. 6000 rpm 离心 5 min,保留约 100 μl 上清重悬菌体,涂布到对应抗性的 LB 平板。
  6. 平板倒置 37 ℃ 培养 14 h(30 ℃ 则 20 h)。菌落过多可稀释质粒后再转化;无菌落可增加至 10 μl 质粒。建议先转克隆感受态、重提质粒后再导入表达感受态。
  7. 挑取单菌落接种 LB 液体培养基,加入对应抗生素,220 rpm 振荡培养 14 h,按试剂盒说明提取质粒。

通用质粒转化方法

  1. 取100 μL感受态细胞置于冰上解冻10 min,加入2 μL质粒,冰浴30 min;随后42 ℃热激60 s,期间不要晃动,再冰浴2 min。
  2. 加入900 μL无抗LB液体培养基,37 ℃、180 rpm振荡培养45 min(30 ℃条件下则培养1–1.5 h)。
  3. 6000 rpm离心5 min,弃上清,仅保留100 μL上清重悬菌体沉淀,涂布于对应质粒抗性的LB平板上。
  4. 平板倒置培养,37 ℃培养14 h,或30 ℃培养20 h。
  5. 挑取单菌落至LB液体培养基中,加入对应抗生素,220 rpm振荡培养14 h;根据实验需求及质粒提取试剂盒说明书提取质粒。

pAYE 质粒 (编号: V009383) 注释

LOCUS       40924_5159        4603 bp DNA     circular SYN 17-DEC-2018
DEFINITION  Phagemid vector pAYE, complete sequence.
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
REFERENCE   1  (bases 1 to 4603)
  AUTHORS   Yee A, Tan F-L., Ginsburg D.
  TITLE     Functional display of platelet-binding VWF fragments on filamentous 
            bacteriophage
  JOURNAL   PLoS ONE 8 (9), E73518 (2013)
  PUBMED    24019925
REFERENCE   2  (bases 1 to 4603)
  AUTHORS   Yee A, Tan F-L., Ginsburg D.
  TITLE     Direct Submission
  JOURNAL   Submitted (07-JUL-2013) Life Scieneces Institute, University of 
            Michigan, 210 Washtenaw Ave, Ann Arbor, MI 48109, USA
REFERENCE   3  (bases 1 to 4603)
  TITLE     Direct Submission
REFERENCE   4  (bases 1 to 4603)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "PLoS ONE"; 
            date: "2013"; volume: "8"; issue: "9"; pages: "E73518"
COMMENT     SGRef: number: 2; type: "Journal Article"; journalName: "Submitted 
            (07-JUL-2013) Life Scieneces Institute, University of Michigan, 210 
            Washtenaw Ave, Ann Arbor, MI 48109, USA"
COMMENT     SGRef: number: 3; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..4603
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     promoter        96..200
                     /label=AmpR promoter
     CDS             201..1058
                     /label=AmpR
                     /note="beta-lactamase"
     rep_origin      1232..1820
                     /label=ori
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                     replication"
     protein_bind    2108..2129
                     /label=CAP binding site
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     promoter        2144..2174
                     /label=lac promoter
                     /note="promoter for the E. coli lac operon"
     protein_bind    2182..2198
                     /label=lac operator
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be 
                     relieved by adding lactose or 
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     primer_bind     2206..2222
                     /label=M13 rev
                     /note="common sequencing primer, one of multiple similar 
                     variants"
     CDS             2269..3723
                     /codon_start=1
                     /transl_except="(pos: 2326 .. 2328,  aa: OTHER)"
                     /product="VWF A1-pIII fusion protein"
                     /label=VWF A1-pIII fusion protein
                     /note="stop codon is suppressed in Eshcerichia coli
                     containing the glnV mutation (supE)"
                     /protein_id="AHB62418.1"
                     /translation="MRVLLFLLLSLFMLPAFSA*PAGAPGGQEPGGLVVPPTDAPVSPT
                     TLYVEDISEPPLHDFYCSRLLDLVFLLDGSSRLSEAEFEVLKAFVVDMMERLRISQKWV
                     RVAVVEYHDGSHAYIGLKDRKRPSELRRIASQVKYAGSQVASTSEVLKYTLFQIFSKID
                     RPEASRIALLLMASQEPQRMSRNFVRYVQGLKKKKVIVIPVGIGPHANLKQIRLIEKQA
                     PENKAFVLSSVDELEQQRDEIVSYLCDLAPEAPPPTLPPDMAQVGGGRAAAAGAPVPYP
                     DPLEPRAAQGGGSGGGSGGGSEGGGSEGGGSEGGGSEGGGSEGGGSGGGSGSGDFDYEK
                     MANANKGAMTENADENALQSDAKGKLDSVATDYGAAIDGFIGDVSGLANGNGATGDFAG
                     SNSQMAQVGDGDNSPLMNNFRQYLPSLPQSVECRPYVFGAGKPYEFSIDCDKINLFRGV
                     FAFLLYVATFMYVFSTFANILRNKES"
     sig_peptide     2269..3720
     misc_feature    2326..2328
                     /label=amber stop
                     /note="amber stop"
     primer_bind     complement(3733..3749)
                     /label=M13 fwd
                     /note="common sequencing primer, one of multiple similar 
                     variants"
     rep_origin      3962..4417
                     /direction=RIGHT
                     /label=f1 ori
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"